Articles related to HEALTHCARE ACCESS

Mike Serbinis, CEO of League; Pete Anevski, CEO of Progyny; John Erwin, CEO of Carenet Health; Mick Mazour, president of Carenet Health; BJ Schaknowski, CEO of symplr; Tanja Dowe, CEO of the Debiopharm Innovation Fund; Derek Streat, Co-founder and CEO of DexCare; and Kimberly O’Loughlin, CEO of Health Recovery Solutions, provide their thoughts on this year’s meeting, with value-based care, healthcare technology, hospital medicine, and the overall economy being the familiar strings.

According to a University of Washington research, only 40% of rural counties nationally had at least one licensed physician who could prescribe buprenorphine in 2016. The analysis discovered that by 2020, that number had increased to 63%. The increase was attributed by the study to modifications in federal regulations that permit NPs, PAs, and other healthcare professionals to prescribe buprenorphine. Only doctors could perform this in the past, and many remote counties lacked any. In 2002, Suboxone received approval from federal regulators, providing a new option for addiction treatment in communities without methadone facilities. Marshalltown, a town of 27,000 people encircled by rural areas, offers a feasible alternative, according to Andrea Storjohann, NP.

Teva Pharmaceuticals is the primary supplier of both branded and generic versions of the stimulant, which is approved to treat ADHD and narcolepsy. Teva has cited increased demand, workforce shortages, and manufacturing disruptions due to packaging constraints as reasons for the supply problems.

A cohort study of 1,024 patients at an urban academic medical center discovered that 13% of oral anticancer drug prescriptions were never filled. The most common reason for failure to receive an oral anticancer drug prescription was due to patient and clinician decision-making; 13% of cases of failure to receive an oral anticancer drug prescription were directly associated with financial access issues.

An estimated 72% of people who need mental heath care don’t have sufficient access to receive it. Psychologists have had limited prescribing rights in several states since the 1990s. Would expanding those privileges to more states help abate the crisis?

In a 2021 poll conducted by West Health and Gallup, 7% of American respondents said they had difficulty paying for at least one prescription drug in the previous three months. The same survey also found that 1 in 10 Americans had skipped medication doses in the previous year in order to save money. The well-known billionaire Mark Cuban is aiming to alter that with the Mark Cuban Cost Plus Drug Company, which will lower the cost and provide access to hundreds of prescriptions for people all around the nation. “Everyone should have safe, affordable medicines with transparent prices.” Mark Cuban